Heuberger, D.M.; Wolint, P.; Jang, J.-H.; Itani, S.; Jungraithmayr, W.; Waschkies, C.F.; Meier-Bürgisser, G.; Andreoli, S.; Spanaus, K.; Schuepbach, R.A.;
et al. High-Affinity Cu(I)-Chelator with Potential Anti-Tumorigenic Action—A Proof-of-Principle Experimental Study of Human H460 Tumors in the CAM Assay. Cancers 2022, 14, 5122.
https://doi.org/10.3390/cancers14205122
AMA Style
Heuberger DM, Wolint P, Jang J-H, Itani S, Jungraithmayr W, Waschkies CF, Meier-Bürgisser G, Andreoli S, Spanaus K, Schuepbach RA,
et al. High-Affinity Cu(I)-Chelator with Potential Anti-Tumorigenic Action—A Proof-of-Principle Experimental Study of Human H460 Tumors in the CAM Assay. Cancers. 2022; 14(20):5122.
https://doi.org/10.3390/cancers14205122
Chicago/Turabian Style
Heuberger, Dorothea M., Petra Wolint, Jae-Hwi Jang, Saria Itani, Wolfgang Jungraithmayr, Conny F. Waschkies, Gabriella Meier-Bürgisser, Stefano Andreoli, Katharina Spanaus, Reto A. Schuepbach,
and et al. 2022. "High-Affinity Cu(I)-Chelator with Potential Anti-Tumorigenic Action—A Proof-of-Principle Experimental Study of Human H460 Tumors in the CAM Assay" Cancers 14, no. 20: 5122.
https://doi.org/10.3390/cancers14205122
APA Style
Heuberger, D. M., Wolint, P., Jang, J.-H., Itani, S., Jungraithmayr, W., Waschkies, C. F., Meier-Bürgisser, G., Andreoli, S., Spanaus, K., Schuepbach, R. A., Calcagni, M., Fahrni, C. J., & Buschmann, J.
(2022). High-Affinity Cu(I)-Chelator with Potential Anti-Tumorigenic Action—A Proof-of-Principle Experimental Study of Human H460 Tumors in the CAM Assay. Cancers, 14(20), 5122.
https://doi.org/10.3390/cancers14205122
